Tracking of blood pressure over a 40-year period in the University of Manitoba Follow-up Study, 1948-1988.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 7572975)

Published in Am J Epidemiol on November 01, 1995

Authors

R B Tate1, J Manfreda, A D Krahn, T E Cuddy

Author Affiliations

1: Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.

Articles by these authors

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (1987) 8.41

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med (1995) 6.49

A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med (1993) 3.75

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26

Tuberculosis surveillance in immigrants to Manitoba. CMAJ (1990) 2.32

Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol (2001) 1.98

A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch Pediatr Adolesc Med (2000) 1.85

Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med (1982) 1.80

Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart (2004) 1.77

Where Manitoba children obtain their cigarettes. CMAJ (1987) 1.71

Radiological changes after withdrawal from asbestos exposure. Br J Ind Med (1979) 1.70

The effect of age on risk factors for ischemic heart disease: the Manitoba Follow-Up Study, 1948-1993. Ann Epidemiol (1998) 1.66

Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals. Am J Cardiol (1975) 1.61

Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep (1999) 1.53

Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation (2000) 1.51

Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. JAMA (1991) 1.50

Income level and asthma prevalence and care patterns. Am J Respir Crit Care Med (1997) 1.44

Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest (1998) 1.42

Exposure and sensitization to cat dander: asthma and asthma-like symptoms among adults. J Allergy Clin Immunol (1999) 1.31

The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest (1991) 1.31

The emergency department is a determinant point of contact of tuberculosis patients prior to diagnosis. Int J Tuberc Lung Dis (2002) 1.24

Health care utilization in the 10 years prior to diagnosis in obstructive sleep apnea syndrome patients. Sleep (1999) 1.24

The use of health-care resources in obesity-hypoventilation syndrome. Chest (2001) 1.24

The natural history of primary first-degree atrioventricular heart block. N Engl J Med (1986) 1.23

Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med (1995) 1.20

Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol (2001) 1.19

Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country. Eur Respir J (2011) 1.17

Tuberculosis status and social adaptation of Indochinese refugees. Int Migr Rev (1987) 1.17

Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med (2000) 1.15

The natural history of electrocardiographic preexcitation in men. The Manitoba Follow-up Study. Ann Intern Med (1992) 1.15

Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med (1996) 1.14

Occupational asthma in adults in six Canadian communities. Am J Respir Crit Care Med (2000) 1.13

Geographical variations in the prevalence of atopic sensitization in six study sites across Canada. Allergy (2010) 1.11

Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis (1995) 1.08

Cord blood IgE: its determinants and prediction of development of asthma and other allergic disorders at 12 months. Ann Allergy Asthma Immunol (2000) 1.08

Antituberculous drug resistance in Manitoba from 1980 to 1989. CMAJ (1993) 1.08

The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis. Am J Public Health (1991) 1.07

Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun (2003) 1.04

Serum total immunoglobulin E levels in Canadian adults. J Allergy Clin Immunol (1984) 1.03

Respiratory symptoms in Manitoba farmers: association with grain and hay handling. Can Med Assoc J (1980) 1.02

Respiratory symptoms in a susceptible population due to burning of agricultural residue. Chest (1998) 1.02

M. tuberculosis molecular variation in CNS infection: evidence for strain-dependent neurovirulence. Neurology (1998) 0.98

A population-based study of tuberculosis epidemiology and innovative service delivery in Canada. Int J Tuberc Lung Dis (2012) 0.97

Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti. Am Rev Respir Dis (1991) 0.97

The role of perceived overprotectiveness in recovery 3 months after myocardial infarction. J Cardiopulm Rehabil (1997) 0.97

Mite and cat allergen levels in homes and severity of asthma. Am J Respir Crit Care Med (1995) 0.96

Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am Heart J (2000) 0.96

Spirometry and obstructive lung disease in Manitoba. Can Respir J (2001) 0.96

Disseminated tuberculosis with and without a miliary pattern on chest radiograph: a clinical-pathologic-radiologic correlation. Int J Tuberc Lung Dis (1997) 0.96

Two-step tuberculin testing in staff and residents of a nursing home. Am Rev Respir Dis (1993) 0.95

Transmission characteristics of tuberculosis in the foreign-born and the Canadian-born populations of Alberta, Canada. Int J Tuberc Lung Dis (2004) 0.95

The relationship between smoking and total immunoglobulin E levels. J Allergy Clin Immunol (1982) 0.95

Respiratory abnormalities in employees of the hard rock mining industry. Am Rev Respir Dis (1982) 0.94

Implantable loop recorder: evaluation of unexplained syncope. Heart (1999) 0.92

Recruiting healthy participants for a large clinical trial. Control Clin Trials (1993) 0.92

Unipolar electrogram characteristics predictive of successful radiofrequency catheter ablation of accessory pathways. J Cardiovasc Electrophysiol (2000) 0.91

Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. Am Heart J (2001) 0.90

Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry. J Cardiovasc Electrophysiol (2010) 0.90

Umbilical cord blood mononuclear cell proliferative response to house dust mite does not predict the development of allergic rhinitis and asthma. J Allergy Clin Immunol (1999) 0.88

Breast-feeding and environmental tobacco smoke exposure. Arch Pediatr Adolesc Med (1999) 0.88

Cardiovascular medication use in patients with undiagnosed obstructive sleep apnoea. Thorax (2002) 0.88

Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases. Can Respir J (2005) 0.87

A cost effective approach to the investigation of syncope: relative merit of different diagnostic strategies. Can J Cardiol (1999) 0.87

Oxidative status of lipoproteins in coronary disease patients. Am Heart J (1992) 0.87

Prevalence of respiratory abnormalities in a rural and an urban community. Am Rev Respir Dis (1978) 0.86

Pulmonary tuberculosis, human immunodeficiency virus type-1 and malnutrition. Bull Int Union Tuberc Lung Dis (1991) 0.86

Risk factors for reactivation of tuberculosis in Manitoba. CMAJ (1985) 0.86

Upper airway resistance syndrome: effect of nasal dilation, sleep stage, and sleep position. Sleep (1999) 0.86

House dust mite allergen levels in two cities in Canada: effects of season, humidity, city and home characteristics. Clin Exp Allergy (1995) 0.86

The role of symptomatic colds in asthma exacerbations: Influence of outdoor allergens and air pollutants. J Allergy Clin Immunol (2001) 0.85

Acute symptoms following exposure to grain dust in farming. Environ Health Perspect (1986) 0.85

The epidemiology of tuberculosis among foreign-born persons in Alberta, Canada, 1989-1998: identification of high risk groups. Int J Tuberc Lung Dis (2002) 0.84

The costs of recurrent syncope of unknown origin in elderly patients. Pacing Clin Electrophysiol (1999) 0.84

Atrioventricular node reentry with 'smooth' AV node function curves: a different arrhythmia substrate? Circulation (1996) 0.83

Changes in asthma severity in Manitoba. Chest (1995) 0.83

Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease. Can Med Assoc J (1980) 0.83

Evidence that height is an independent risk factor for coronary artery disease (the Manitoba Follow-Up Study). Am J Cardiol (1994) 0.82

Clinical trial of naloxone in birth asphyxia. J Pediatr (1988) 0.82

Recommendations for ECG diagnostic coding. Prepared by Working Group 'Diagnostic Codes'. Eur J Cardiol (1978) 0.81

Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Anesthesiology (1999) 0.81

A case-control study of the role of cold symptoms and other historical triggering factors in asthma exacerbations. Can Respir J (2000) 0.81

Major cat allergen (Fel d I) levels in the homes of patients with asthma and their relationship to sensitization to cat dander. Ann Allergy Asthma Immunol (1995) 0.81

Inhalation of low (0.5%-1.5%) CO2 as a potential treatment for apnea of prematurity. Semin Perinatol (2001) 0.80

Diagnostic assessment of recurrent unexplained syncope with a new subcutaneously implantable loop recorder. Reveal-Investigators. Europace (2000) 0.79

The utility of the programmable pacemaker. Pacing Clin Electrophysiol (1978) 0.79

Correlation of waiting time with adverse events in patients admitted for nonelective permanent pacemaker implantation. Can J Cardiol (1998) 0.78

Prognosis of individuals with atrial fibrillation. Can J Cardiol (1996) 0.78

Canadian Colloquium on Computer-Assisted Interpretation of Electrocardiograms. Can Med Assoc J (1973) 0.78

Supraventricular tachycardia. Med Clin North Am (2001) 0.78

Use of medications in Wolff-Parkinson-White syndrome. Expert Opin Pharmacother (2005) 0.77

Acute testing of the rate-smoothed pacing algorithm for ventricular rate stabilization. Pacing Clin Electrophysiol (1999) 0.77

Alpha1-antitrypsin phenotypes and lung function in a moderately polluted northern Ontario community. Can Med Assoc J (1978) 0.77

Impact of a mandatory physician reporting system for cardiac patients potentially unfit to drive. Can J Cardiol (2000) 0.77

Safety of slow pathway ablation in patients with atrioventricular node reentrant tachycardia and a long fast pathway effective refractory period. Am J Cardiol (1997) 0.76